Tebentafusp approved for eligible patients with advanced uveal melanoma in Scotland
Tebentafusp approved for eligible patients with advanced uveal melanoma in Scotland Ocular Melanoma UK has welcomed today’s decision by the Scottish Medicines Consortium (SMC) to approve tebentafusp (Kimmtrak®) for eligible adults with advanced uveal melanoma. The decision means tebentafusp is now available for prescribing on the NHS in Scotland for adults who are HLA-A*02:01 positive […]
Tebentafusp approved for eligible patients with advanced uveal melanoma in Scotland Read More »

